Variant report

Variant	rs561723968
Chromosome Location	chr10:22610365-22610366
allele	-/GAGGCG
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	MAX	chr10:22610357-22610553	H1-hESC	embryonic stem cell:	n/a	n/a
2	POLR2A	chr10:22609287-22611229	GM19193	blood:	n/a	n/a
3	UBTF	chr10:22608591-22610646	K562	blood:	n/a	n/a
4	TAF1	chr10:22610089-22610564	K562	blood:	n/a	n/a
5	YY1	chr10:22609731-22610738	GM12891	blood:	n/a	chr10:22610512-22610534 chr10:22610460-22610474 chr10:22610008-22610016 chr10:22610525-22610533 chr10:22610524-22610534 chr10:22609887-22609901 chr10:22610517-22610536 chr10:22610523-22610531
6	POLR2A	chr10:22610140-22610747	Hela-S3	cervix:	n/a	n/a
7	POLR2A	chr10:22609796-22610666	GM12878	blood:	n/a	n/a
8	YY1	chr10:22610102-22610782	SK-N-SH_RA	brain:	n/a	chr10:22610512-22610534 chr10:22610460-22610474 chr10:22610525-22610533 chr10:22610524-22610534 chr10:22610517-22610536 chr10:22610523-22610531
9	POLR2A	chr10:22609701-22610669	HL-60	blood:	n/a	n/a
10	RCOR1	chr10:22610287-22610489	GM12878	blood:	n/a	n/a
11	ZBTB7A	chr10:22609647-22610509	ECC-1	luminal epithelium:	n/a	chr10:22610261-22610270
12	POLR2A	chr10:22610152-22610619	A549	lung:	n/a	n/a
13	EP300	chr10:22609992-22610567	ECC-1	luminal epithelium:	n/a	chr10:22610467-22610483
14	MAX	chr10:22610143-22610639	ECC-1	luminal epithelium:	n/a	n/a
15	TAF1	chr10:22610164-22610659	GM12878	blood:	n/a	n/a
16	YY1	chr10:22610203-22610733	A549	lung:	n/a	chr10:22610512-22610534 chr10:22610460-22610474 chr10:22610525-22610533 chr10:22610524-22610534 chr10:22610517-22610536 chr10:22610523-22610531
17	TCF12	chr10:22609681-22610656	ECC-1	luminal epithelium:	n/a	n/a
18	POLR2A	chr10:22609207-22611164	GM18951	blood:	n/a	n/a
19	POLR2A	chr10:22609272-22610661	K562	blood:	n/a	n/a
20	YY1	chr10:22609771-22610653	HCT-116	colon:	n/a	chr10:22610512-22610534 chr10:22610460-22610474 chr10:22610008-22610016 chr10:22610525-22610533 chr10:22610524-22610534 chr10:22609887-22609901 chr10:22610517-22610536 chr10:22610523-22610531
21	SIN3AK20	chr10:22610264-22610573	PFSK-1	brain:	n/a	n/a
22	E2F6	chr10:22610177-22610511	K562	blood:	n/a	chr10:22610464-22610474
23	MAZ	chr10:22608776-22611595	IMR90	lung:	n/a	chr10:22609951-22609970 chr10:22609956-22609965 chr10:22609955-22609966 chr10:22611023-22611032 chr10:22609954-22609967
24	YY1	chr10:22609990-22610859	SK-N-SH	brain:	n/a	chr10:22610512-22610534 chr10:22610460-22610474 chr10:22610008-22610016 chr10:22610525-22610533 chr10:22610524-22610534 chr10:22610517-22610536 chr10:22610523-22610531
25	MAX	chr10:22610319-22610576	HepG2	liver:	n/a	n/a
26	HA-E2F1	chr10:22610162-22610640	MCF-7	breast:	n/a	chr10:22610464-22610474 chr10:22610606-22610616
27	GABPA	chr10:22610261-22610550	H1-hESC	embryonic stem cell:	n/a	chr10:22610269-22610278 chr10:22610271-22610280
28	MAX	chr10:22609764-22610546	NB4	blood:	n/a	chr10:22609951-22609970 chr10:22609956-22609965 chr10:22609955-22609966 chr10:22609954-22609967
29	MAZ	chr10:22609550-22610623	HepG2	liver:	n/a	chr10:22609951-22609970 chr10:22609956-22609965 chr10:22609955-22609966 chr10:22609954-22609967
30	POLR2A	chr10:22609757-22610617	K562	blood:	n/a	n/a
31	CREB1	chr10:22609539-22610672	A549	lung:	n/a	n/a
32	POLR2A	chr10:22610117-22610561	A549	lung:	n/a	n/a
33	YY1	chr10:22609657-22610755	K562	blood:	n/a	chr10:22610512-22610534 chr10:22610523-22610531 chr10:22610525-22610533 chr10:22609887-22609901 chr10:22610460-22610474 chr10:22610517-22610536 chr10:22610008-22610016 chr10:22610524-22610534
34	USF1	chr10:22609650-22610449	SK-N-SH	brain:	n/a	chr10:22609956-22609965 chr10:22609957-22609966 chr10:22609956-22609965 chr10:22609955-22609966
35	SIN3A	chr10:22610295-22610570	GM12878	blood:	n/a	n/a
36	MXI1	chr10:22609632-22610648	HepG2	liver:	n/a	n/a
37	FOXM1	chr10:22610045-22610652	GM12878	blood:	n/a	n/a
38	YY1	chr10:22610206-22610695	H1-hESC	embryonic stem cell:	n/a	chr10:22610512-22610534 chr10:22610460-22610474 chr10:22610525-22610533 chr10:22610524-22610534 chr10:22610517-22610536 chr10:22610523-22610531
39	YY1	chr10:22609791-22610782	ECC-1	luminal epithelium:	n/a	chr10:22610512-22610534 chr10:22610460-22610474 chr10:22610008-22610016 chr10:22610525-22610533 chr10:22610524-22610534 chr10:22609887-22609901 chr10:22610517-22610536 chr10:22610523-22610531
40	THAP1	chr10:22610220-22610430	K562	blood:	n/a	n/a
41	CTCF	chr10:22610340-22610490	AG04449	skin:	n/a	chr10:22610432-22610445
42	E2F6	chr10:22610100-22610683	H1-hESC	embryonic stem cell:	n/a	chr10:22610464-22610474 chr10:22610606-22610616
43	TCF7L2	chr10:22609513-22610612	HCT-116	colon:	n/a	n/a
44	ZBTB7A	chr10:22610073-22610415	K562	blood:	n/a	chr10:22610261-22610270
45	YY1	chr10:22609923-22610729	K562	blood:	n/a	chr10:22610512-22610534 chr10:22610460-22610474 chr10:22610008-22610016 chr10:22610525-22610533 chr10:22610524-22610534 chr10:22610517-22610536 chr10:22610523-22610531
46	POLR2A	chr10:22609256-22610729	GM18505	blood:	n/a	n/a
47	MYC	chr10:22609647-22610674	K562	blood:	n/a	chr10:22609951-22609970 chr10:22609956-22609965 chr10:22609955-22609966 chr10:22609954-22609967
48	MAX	chr10:22610093-22610655	SK-N-SH	brain:	n/a	n/a
49	ELF1	chr10:22610181-22610681	GM12878	blood:	n/a	chr10:22610435-22610444
50	MAX	chr10:22610203-22610647	GM12878	blood:	n/a	n/a

No.	Distal block	Cell Line	Cell type
1	chr10:22288734..22294902-chr10:22609249..22612882,8	MCF-7	breast:
2	chr10:22289174..22294396-chr10:22603847..22611692,9	K562	blood:
3	chr10:22608333..22611559-chr10:22678806..22682635,4	K562	blood:
4	chr10:21784438..21786291-chr10:22610167..22612882,2	MCF-7	breast:
5	chr10:22608172..22617536-chr10:22624000..22632852,24	MCF-7	breast:
6	chr10:21823004..21824663-chr10:22608853..22611559,3	K562	blood:
7	chr10:22606981..22611063-chr10:23000780..23004970,4	K562	blood:
8	chr10:22536525..22546833-chr10:22602936..22612723,20	MCF-7	breast:
9	chr10:22607781..22611461-chr10:22678220..22681015,4	K562	blood:

Variant related genes	Relation type
BMI1	TF binding region
ENSG00000272366	Chromatin interaction
ENSG00000136770	Chromatin interaction
ENSG00000077327	Chromatin interaction
ENSG00000222071	Chromatin interaction
ENSG00000078403	Chromatin interaction
ENSG00000150867	Chromatin interaction
ENSG00000261671	Chromatin interaction
ENSG00000204682	Chromatin interaction

Extended variants
information (count: 32 )
Associated
traits (count: 0)

Variant overlapped rSNPs/rCNVs (count:32 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv825292	chr10:22560347-22642200	Bivalent Enhancer Weak transcription Enhancers Flanking Bivalent TSS/Enh Active TSS Bivalent/Poised TSS Flanking Active TSS ZNF genes & repeats Strong transcription Transcr. at gene 5' and 3' Genic enhancers	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	27 gene(s)	inside rSNPs	diseases
2	nsv825293	chr10:22575226-22637618	Enhancers Bivalent/Poised TSS Flanking Active TSS Weak transcription Flanking Bivalent TSS/Enh Genic enhancers Bivalent Enhancer Active TSS Strong transcription ZNF genes & repeats Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	27 gene(s)	inside rSNPs	diseases
3	nsv825294	chr10:22590627-22644910	Flanking Active TSS Weak transcription Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Strong transcription Active TSS Enhancers Genic enhancers ZNF genes & repeats Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	27 gene(s)	inside rSNPs	diseases
4	nsv825295	chr10:22591275-22643207	Flanking Bivalent TSS/Enh Active TSS Enhancers Weak transcription Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3' Strong transcription Flanking Active TSS Genic enhancers ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	27 gene(s)	inside rSNPs	diseases
5	nsv825296	chr10:22591339-22638994	Enhancers Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS Weak transcription Transcr. at gene 5' and 3' Strong transcription ZNF genes & repeats Genic enhancers	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	27 gene(s)	inside rSNPs	diseases
6	nsv894950	chr10:22591830-22639903	Strong transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Enhancers Flanking Active TSS Weak transcription Bivalent Enhancer Transcr. at gene 5' and 3' ZNF genes & repeats Genic enhancers	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	27 gene(s)	inside rSNPs	diseases
7	nsv894951	chr10:22594765-22616244	Weak transcription Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Enhancers Active TSS Strong transcription Genic enhancers Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	20 gene(s)	inside rSNPs	diseases
8	nsv894952	chr10:22594765-22618544	Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Active TSS Bivalent/Poised TSS Weak transcription Bivalent Enhancer Transcr. at gene 5' and 3' Strong transcription Genic enhancers ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	21 gene(s)	inside rSNPs	diseases
9	nsv894953	chr10:22594765-22619304	Weak transcription Genic enhancers Active TSS Bivalent Enhancer Flanking Active TSS Bivalent/Poised TSS Enhancers Strong transcription Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	21 gene(s)	inside rSNPs	diseases
10	nsv894954	chr10:22594765-22621960	Active TSS Enhancers Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Weak transcription Flanking Active TSS Strong transcription Genic enhancers ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	22 gene(s)	inside rSNPs	diseases
11	esv1817463	chr10:22594765-22626662	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription Flanking Bivalent TSS/Enh Bivalent/Poised TSS Strong transcription Active TSS Transcr. at gene 5' and 3' Genic enhancers ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	22 gene(s)	inside rSNPs	diseases
12	nsv894955	chr10:22594765-22631256	Active TSS Bivalent Enhancer Bivalent/Poised TSS Enhancers Flanking Active TSS Strong transcription Flanking Bivalent TSS/Enh Genic enhancers Weak transcription Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	27 gene(s)	inside rSNPs	diseases
13	nsv894956	chr10:22594765-22633193	Bivalent Enhancer Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription Genic enhancers Enhancers Strong transcription Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	27 gene(s)	inside rSNPs	diseases
14	nsv894957	chr10:22594765-22637381	Active TSS Weak transcription Enhancers Strong transcription ZNF genes & repeats Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Transcr. at gene 5' and 3' Genic enhancers	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	27 gene(s)	inside rSNPs	diseases
15	esv1816646	chr10:22594765-22639707	Bivalent/Poised TSS Flanking Active TSS Enhancers Strong transcription Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Weak transcription Genic enhancers Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	27 gene(s)	inside rSNPs	diseases
16	nsv894958	chr10:22594765-22639903	Enhancers Weak transcription Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Genic enhancers Flanking Bivalent TSS/Enh Strong transcription Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	27 gene(s)	inside rSNPs	diseases
17	esv1791996	chr10:22595781-22616437	Active TSS Bivalent/Poised TSS Weak transcription Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Bivalent Enhancer Transcr. at gene 5' and 3' Strong transcription Genic enhancers	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	21 gene(s)	inside rSNPs	diseases
18	nsv825297	chr10:22596793-22637576	Bivalent Enhancer Active TSS Weak transcription Enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Strong transcription Genic enhancers ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	27 gene(s)	inside rSNPs	diseases
19	nsv825299	chr10:22596793-22638994	Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Bivalent/Poised TSS Weak transcription Strong transcription Bivalent Enhancer Active TSS ZNF genes & repeats Transcr. at gene 5' and 3' Genic enhancers	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	27 gene(s)	inside rSNPs	diseases
20	esv1820141	chr10:22597467-22625441	Bivalent Enhancer Flanking Active TSS Weak transcription Flanking Bivalent TSS/Enh Active TSS Strong transcription Enhancers Genic enhancers Bivalent/Poised TSS ZNF genes & repeats Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	22 gene(s)	inside rSNPs	diseases
21	nsv550204	chr10:22601976-22616270	Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription Active TSS Bivalent/Poised TSS Strong transcription Bivalent Enhancer Enhancers Transcr. at gene 5' and 3' Genic enhancers	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	20 gene(s)	inside rSNPs	diseases
22	nsv550205	chr10:22601976-22616784	Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription Genic enhancers Active TSS Bivalent/Poised TSS Strong transcription Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	21 gene(s)	inside rSNPs	diseases
23	nsv894959	chr10:22602013-22619304	ZNF genes & repeats Bivalent/Poised TSS Enhancers Active TSS Transcr. at gene 5' and 3' Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Strong transcription Genic enhancers	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	21 gene(s)	inside rSNPs	diseases
24	nsv550206	chr10:22603318-22616270	Flanking Active TSS Bivalent/Poised TSS Weak transcription Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Active TSS Strong transcription Transcr. at gene 5' and 3' Genic enhancers	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	20 gene(s)	inside rSNPs	diseases
25	nsv550207	chr10:22605112-22631256	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Flanking Active TSS Weak transcription Enhancers Bivalent Enhancer Active TSS Strong transcription Transcr. at gene 5' and 3' Genic enhancers ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	27 gene(s)	inside rSNPs	diseases
26	nsv550208	chr10:22607432-22615763	Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers Strong transcription Genic enhancers Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	12 gene(s)	inside rSNPs	diseases
27	esv3321548	chr10:22607546-22611844	Enhancers Weak transcription Active TSS Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	10 gene(s)	inside rSNPs	diseases
28	nsv550209	chr10:22607829-22615491	Bivalent Enhancer Bivalent/Poised TSS Enhancers Weak transcription Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Transcr. at gene 5' and 3' Genic enhancers Strong transcription	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	12 gene(s)	inside rSNPs	diseases
29	esv3342642	chr10:22608771-22612319	Enhancers Bivalent/Poised TSS Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Weak transcription Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region	10 gene(s)	inside rSNPs	diseases
30	esv16014	chr10:22609123-22617566	Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Weak transcription Enhancers Active TSS Strong transcription Genic enhancers Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA	12 gene(s)	inside rSNPs	diseases
31	esv3371849	chr10:22609246-22611144	Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Enhancers	TF binding region CpG island Chromatin interactive region	9 gene(s)	inside rSNPs	diseases
32	esv3326480	chr10:22609396-22611644	Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Active TSS Transcr. at gene 5' and 3' Flanking Active TSS Weak transcription Enhancers	TF binding region CpG island Chromatin interactive region	9 gene(s)	inside rSNPs	diseases

No data

Chromatin state (count:125 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr10:22608800-22611000	Active TSS	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
2	chr10:22608800-22611000	Active TSS	Brain Hippocampus Middle	brain
3	chr10:22608800-22611000	Bivalent/Poised TSS	Thymus	Thymus
4	chr10:22608800-22611400	Bivalent/Poised TSS	Brain Germinal Matrix	brain
5	chr10:22608800-22611800	Active TSS	HSMMtube	muscle
6	chr10:22608800-22612400	Active TSS	Psoas Muscle	Psoas
7	chr10:22609000-22610400	Active TSS	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
8	chr10:22609000-22610400	Active TSS	IMR90 fetal lung fibroblasts Cell Line	lung
9	chr10:22609000-22611000	Active TSS	Primary T helper cells PMA-I stimulated	--
10	chr10:22609000-22611000	Active TSS	Placenta	Placenta
11	chr10:22609000-22611400	Bivalent/Poised TSS	H1 Cell Line	embryonic stem cell
12	chr10:22609000-22611400	Bivalent/Poised TSS	HUES6 Cell Line	embryonic stem cell
13	chr10:22609000-22611600	Active TSS	Stomach Smooth Muscle	stomach
14	chr10:22609000-22611800	Active TSS	Aorta	Aorta
15	chr10:22609000-22611800	Active TSS	Ovary	ovary
16	chr10:22609000-22612000	Active TSS	Right Ventricle	heart
17	chr10:22609200-22610400	Active TSS	Fetal Intestine Small	intestine
18	chr10:22609200-22610400	Active TSS	Sigmoid Colon	Sigmoid Colon
19	chr10:22609200-22610600	Active TSS	Esophagus	oesophagus
20	chr10:22609200-22611000	Active TSS	H1 Derived Mesenchymal Stem Cells	ES cell derived
21	chr10:22609200-22611000	Active TSS	Primary B cells from peripheral blood	blood
22	chr10:22609200-22611000	Active TSS	Primary T cells effector/memory enriched fromperipheralblood	blood
23	chr10:22609200-22611000	Active TSS	Primary Natural Killer cells fromperipheralblood	blood
24	chr10:22609200-22611000	Active TSS	Colonic Mucosa	Colon
25	chr10:22609200-22611000	Active TSS	Small Intestine	intestine
26	chr10:22609200-22611000	Active TSS	HSMM	muscle
27	chr10:22609200-22611000	Active TSS	NHLF	lung
28	chr10:22609200-22611200	Bivalent/Poised TSS	HUES48 Cell Line	embryonic stem cell
29	chr10:22609200-22611200	Active TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
30	chr10:22609200-22611200	Active TSS	Primary T helper naive cells fromperipheralblood	blood
31	chr10:22609200-22611200	Active TSS	Adipose Nuclei	Adipose
32	chr10:22609200-22611200	Active TSS	Fetal Kidney	kidney
33	chr10:22609200-22611200	Active TSS	Left Ventricle	heart
34	chr10:22609200-22611200	Active TSS	Rectal Smooth Muscle	rectum
35	chr10:22609200-22611200	Active TSS	Skeletal Muscle Male	skeletal muscle
36	chr10:22609200-22611200	Active TSS	Hela-S3	cervix
37	chr10:22609200-22611200	Active TSS	K562	blood
38	chr10:22609200-22611400	Bivalent/Poised TSS	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
39	chr10:22609200-22611400	Bivalent/Poised TSS	HUES64 Cell Line	embryonic stem cell
40	chr10:22609200-22611400	Active TSS	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
41	chr10:22609200-22611600	Bivalent/Poised TSS	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
42	chr10:22609200-22611600	Active TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
43	chr10:22609200-22611600	Active TSS	Breast Myoepithelial Primary Cells	Breast
44	chr10:22609200-22611600	Active TSS	Lung	lung
45	chr10:22609200-22611800	Active TSS	Pancreatic Islets	Pancreatic Islet
46	chr10:22609200-22611800	Active TSS	Pancreas	Pancrea
47	chr10:22609400-22610400	Active TSS	Primary neutrophils fromperipheralblood	blood
48	chr10:22609400-22610400	Active TSS	Primary T helper cells fromperipheralblood	blood
49	chr10:22609400-22610400	Weak transcription	Fetal Brain Male	brain
50	chr10:22609400-22610400	Active TSS	Fetal Brain Female	brain

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links